Uptick in Natriuretic Peptides at Serial Testing Predicts Ne

Serial NT-proBNP assays could potentially identify which of those without clinical disease might most benefit from heart-failure preventive therapies, researchers propose.

Related Keywords

Boston , Massachusetts , United States , Houston , Texas , Baylor College Of Medicine , Xiaoming Jia , Vijay Nambi , Muthiah Vaduganathan , Atherosclerosis Risk In Community , Harvard Medical School , Atherosclerosis Risk , Baylor College , Heart Failure , B Type Natriuretic Peptide , Want , Heart , Hypertension , Risk Management , Preventive Screening , Screening , Biomarker , Iological Marker , Grant , Myocardial Infarction , Atherosclerosis , Boards , Smle , Hospitals , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Uncontrolled Hypertension , Lipids , Ipid Manag ,